Control of vascular permeability by atrial natriuretic peptide via a GEF-H1-dependent mechanism.
about
Nonstructural protein 1 (NS1)-mediated inhibition of c-Abl results in acute lung injury and priming for bacterial co-infections: insights into 1918 H1N1 pandemic?Hepatocyte growth factor triggers distinct mechanisms of Asef and Tiam1 activation to induce endothelial barrier enhancement.Role of microtubules in attenuation of PepG-induced vascular endothelial dysfunction by atrial natriuretic peptide.Hepatocyte growth factor-induced Asef-IQGAP1 complex controls cytoskeletal remodeling and endothelial barrier.Asef mediates HGF protective effects against LPS-induced lung injury and endothelial barrier dysfunction.Oxidized phospholipids protect against lung injury and endothelial barrier dysfunction caused by heat-inactivated Staphylococcus aureus.Effects of atrial natriuretic peptide on inter-organ crosstalk among the kidney, lung, and heart in a rat model of renal ischemia-reperfusion injury.Membrane-anchored proteases in endothelial cell biology.Atrial natriuretic peptide down-regulates neutrophil recruitment on inflamed endothelium by reducing cell deformability and resistance to detachment forceThe role of atrial natriuretic peptide to attenuate inflammation in a mouse skin wound and individually perfused rat mesenteric microvessels.PAK4 suppresses PDZ-RhoGEF activity to drive invadopodia maturation in melanoma cells.Regulatory mechanisms, prophylaxis and treatment of vascular leakage following severe trauma and shock.Role of Cingulin in Agonist-induced Vascular Endothelial Permeability.Everything we always wanted to know about furosemide but were afraid to ask.The role of apical cell-cell junctions and associated cytoskeleton in mechanotransduction.Differential role for PAK1 and PAK4 during the invadopodia lifecycle.Role of End Binding Protein-1 in endothelial permeability response to barrier-disruptive and barrier-enhancing agonists.Role of truncated oxidized phospholipids in acute endothelial barrier dysfunction caused by particulate matter
P2860
Q30368379-0649BF58-6231-49DC-870C-1036664B17A6Q34560850-E0FFA7FB-EE56-4C86-BD7F-0123DDAF53E6Q34715709-839E4235-1BE0-4993-BAF9-26641CBD005DQ35080268-86D327BE-BB66-46A4-99FF-26F02D83FDFCQ35138639-D1084CB7-B7BE-4E53-B078-44E4A14D7866Q35178692-AAC8A02C-4D55-4402-8533-4EA7148D663CQ35883578-0B33F717-9722-4413-BDD7-BC9142377C4BQ36940312-C274DB3A-CCB8-4E1A-9B1A-FBC9386028BDQ37249880-D8472DD2-CB8B-41A3-80B9-444E7B43C723Q37286819-1BEC21CB-8EFC-4B67-9441-785F9A416D31Q37688629-74ABFA58-A452-41C8-BF79-B1D5F845924FQ37726288-EB91C1B7-8302-4418-A87C-89B3B3C34973Q38748503-88A43B58-EFD9-4484-8FB3-D113EAC97C90Q38748880-B665FB7B-FF7E-44F4-AA32-42DCA18B5ADAQ39144944-F5371139-7D6C-47A3-A5F9-C99BB00DC1C4Q39181978-685AFBFA-FAA0-4A92-ADEC-09242897BEDFQ39352462-181978E0-33A9-4744-B1BD-1A70E3E255B9Q59129858-CAF83B12-8F75-439F-B494-E8B050BAFE38
P2860
Control of vascular permeability by atrial natriuretic peptide via a GEF-H1-dependent mechanism.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Control of vascular permeabili ...... a GEF-H1-dependent mechanism.
@en
Control of vascular permeabili ...... a GEF-H1-dependent mechanism.
@nl
type
label
Control of vascular permeabili ...... a GEF-H1-dependent mechanism.
@en
Control of vascular permeabili ...... a GEF-H1-dependent mechanism.
@nl
prefLabel
Control of vascular permeabili ...... a GEF-H1-dependent mechanism.
@en
Control of vascular permeabili ...... a GEF-H1-dependent mechanism.
@nl
P2093
P2860
P356
P1476
Control of vascular permeabili ...... a GEF-H1-dependent mechanism.
@en
P2093
Anna A Birukova
Grzegorz Gawlak
Nicolene Sarich
Tinghuai Wu
Xinyong Tian
Yufeng Tian
P2860
P304
P356
10.1074/JBC.M113.493924
P407
P577
2013-12-18T00:00:00Z